Online: | |
Visits: | |
Stories: |
Story Views | |
Now: | |
Last Hour: | |
Last 24 Hours: | |
Total: |
CBC News Technology developed by the Atlantic Cancer Research Institute and New England Peptide Inc. to test patients for cancer and other diseases through bodily fluids instead of a tissue biopsy has caught global attention. ACRI has reached a licensing agreement … Continue reading →
The post New Brunswick ‘liquid biopsy’ cancer-testing technology goes global appeared first on From the Trenches World Report.